Ceribell

Ceribell is a private medical device company headquartered in Sunnyvale, California, focused on transforming the diagnosis and management of patients with serious neurological conditions. Its core technology is a portable, rapidly deployable EEG platform combined with sophisticated AI algorithms, most notably the Clarity® seizure detection algorithm. The company has achieved significant clinical validation with over 135 publications, FDA clearances for neonates through adults, and demonstrated impact on reducing ICU length of stay and improving patient outcomes.

A point-of-care EEG platform combining rapidly deployable hardware with AI algorithms (Clarity®) for real-time seizure detection and brain monitoring. Includes a secure, FedRAMP High-authorized cloud portal for remote review.

Total raised: $97M

Ceribell competes with traditional conventional EEG services and other portable EEG devices. Its main differentiation lies in its combination of rapid bedside deployment, a clinically validated AI algorithm (Clarity®) with broad age clearance, a strong evidence base demonstrating improved patient outcomes, and a secure, cloud-based platform with FedRAMP High authorization.